COLISTIMETHATE FOR INJECTION USP DIN 02546639
Health Canada record
| Active ingredient(s) | COLISTIMETHATE SODIUM 150 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XB01 COLISTIN |
| Original market date | 10-Jun-2024 |
| Current status date | 10-Jun-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).
No Canadian shortage report is currently matched to this DIN.
International API supply for COLISTIMETHATE SODIUM
3 valid EDQM Certificates of Suitability from 3 holders. 3 active FDA Drug Master Files.
Request a quote for COLISTIMETHATE FOR INJECTION USP